260 related articles for article (PubMed ID: 31804360)
41. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
42. Effective multimodal management of a giant adrenocortical carcinoma.
Pairon C; Dili A; Bertrand C; D'Hondt L; Fervaille C; Donckier JE
Acta Chir Belg; 2023 Aug; 123(4):444-447. PubMed ID: 35137673
[TBL] [Abstract][Full Text] [Related]
43. A child with adrenocortical carcinoma who underwent percutaneous ethanol injection therapy for liver metastasis.
Hara F; Kishikawa T; Tomishige H; Nishikawa O; Nishida Y; Kongo M
J Pediatr Surg; 2003 Aug; 38(8):1237-40. PubMed ID: 12891501
[TBL] [Abstract][Full Text] [Related]
44. Extended survival in a patient with recurrent and metastatic adrenal cortical carcinoma by aggressive transarterial embolization--a case report.
Li SH; Huang CH; Ko SF; Chou FF; Huang SC
J Surg Oncol; 2005 May; 90(2):101-5. PubMed ID: 15844181
[TBL] [Abstract][Full Text] [Related]
45. Oncocytic adrenocortical carcinoma.
Tanaka K; Kumano Y; Kanomata N; Takeda M; Hara I; Fujisawa M; Kawabata G; Kamidono S
Urology; 2004 Aug; 64(2):376-7. PubMed ID: 15302503
[TBL] [Abstract][Full Text] [Related]
46. Adrenocortical Cancer Treatment.
Long SE; Miller BS
Surg Clin North Am; 2019 Aug; 99(4):759-771. PubMed ID: 31255205
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic challenges in adrenocortical carcinoma: recommendations for surveillance after surgical resection of selected adrenal nodules.
Fareau GG; Vassilopoulou-Sellin R
Endocr Pract; 2007 Oct; 13(6):636-41. PubMed ID: 17954420
[TBL] [Abstract][Full Text] [Related]
48. Acute neck pain caused by atlanto-axial instability secondary to pathologic fracture involving odontoid process and C2 vertebral body: treatment with radiofrequency thermoablation, cement augmentation and odontoid screw fixation.
Zwolak P; Kröber M
Arch Orthop Trauma Surg; 2015 Sep; 135(9):1211-5. PubMed ID: 26109440
[TBL] [Abstract][Full Text] [Related]
49. American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach.
Kiseljak-Vassiliades K; Bancos I; Hamrahian A; Habra M; Vaidya A; Levine AC; Else T
Endocr Pract; 2020 Nov; 26(11):1366-1383. PubMed ID: 33875173
[TBL] [Abstract][Full Text] [Related]
50. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options.
Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M
Expert Rev Anticancer Ther; 2018 Nov; 18(11):1125-1133. PubMed ID: 30117750
[TBL] [Abstract][Full Text] [Related]
51. Pigmented adrenocortical carcinoma: case report and review.
Geller JL; Azer PC; Weiss LM; Mertens RB
Endocr Pathol; 2006; 17(3):297-304. PubMed ID: 17308367
[TBL] [Abstract][Full Text] [Related]
52. A systematic review of clinical outcomes for patients diagnosed with skin cancer spinal metastases.
Goodwin CR; Sankey EW; Liu A; Elder BD; Kosztowski T; Lo SF; Fisher CG; Clarke MJ; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2016 May; 24(5):837-49. PubMed ID: 26544595
[TBL] [Abstract][Full Text] [Related]
53. Adrenocortical carcinoma with cerebral metastasis in a child: case report and review of the literature.
Romaguera RL; Minagar A; Bruce JH; Jagid JR; Falcone S; Curless RG; Ragheb J; Morrison G
Clin Neurol Neurosurg; 2001 Apr; 103(1):46-50. PubMed ID: 11311478
[TBL] [Abstract][Full Text] [Related]
54. Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report.
Ohashi K; Hayashi T; Sakamoto M; Iuchi H; Suzuki H; Ebisawa T; Tojo K; Sasano H; Utsunomiya K
BMC Endocr Disord; 2016 Jan; 16():3. PubMed ID: 26772981
[TBL] [Abstract][Full Text] [Related]
55. [Adrenocortical carcinoma detected by retroperitoneal hemorrhage : a case report].
Sakata R; Tsuchiya F; Osaka K; Fujikawa A; Ouchi H; Iwasaki A
Hinyokika Kiyo; 2012 Mar; 58(3):149-53. PubMed ID: 22495043
[TBL] [Abstract][Full Text] [Related]
56. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
57. A clinical study and treatment results of adrenocortical carcinoma patients presented in Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore.
Khan MS; Ali A; Tariq I; Khan MA; Bakar MA; Anwar AW
J Pak Med Assoc; 2019 May; 69(5):717-719. PubMed ID: 31105294
[TBL] [Abstract][Full Text] [Related]
58. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases.
Wood BJ; Abraham J; Hvizda JL; Alexander HR; Fojo T
Cancer; 2003 Feb; 97(3):554-60. PubMed ID: 12548596
[TBL] [Abstract][Full Text] [Related]
59. Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up.
Schwarte S; Brabant EG; Bastian L; Bruns F
Anticancer Res; 2007; 27(4A):1917-20. PubMed ID: 17649795
[TBL] [Abstract][Full Text] [Related]
60. ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.
Yarom N; Stewart D; Avruch L; Malik R; Wells J; Jonker DJ
Anticancer Res; 2011 Nov; 31(11):3921-5. PubMed ID: 22110220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
